Vaccines

15 Mar 2011 Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
14 Mar 2011 Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
11 Mar 2011 AFFiRiS AG: Alzheimer's Vaccination Shows Promising Results
10 Mar 2011 Pepscan Therapeutics Closes a Research and License Agreement Aimed at the Development of Novel Vaccines
10 Mar 2011 Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
08 Mar 2011 LIQUIDIA TECHNOLOGIES RECEIVES SIGNIFICANT EQUITY INVESTMENT TO BOLSTER DEVELOPMENT OF NEXT GENERATION VACCINES
07 Mar 2011 Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon DNA Vaccine for Cervical Dysplasia Caused by HPV
04 Mar 2011 BioSante's Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study
02 Mar 2011 Bayhill Therapeutics Announces the Successful Clearance of an IND for BHT-3034 for the Treatment of Myasthenia Gravis
02 Mar 2011 Baxter’s PREFLUCEL Seasonal Influenza Vaccine Receives European Repeat Mutual Recognition Approval
02 Mar 2011 Vical Receives Positive Scientific Advice From EMA for TransVax Phase 3 Trial
01 Mar 2011 VaxInnate Awarded Contract by the U.S. Government To Develop Recombinant Seasonal and Pandemic Flu Vaccines
01 Mar 2011 Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries
28 Feb 2011 AFFIRIS ANNOUNCES AN EXTENSION OF ITS EXISTING ALZHEIMER´S DISEASE VACCINE DEVELOPMENT COLLABORATION WITH GLAXOSMITHKLINE TRIGGERING A EUR 3.5 MILLION PAYMENT TO AFFiRiS
23 Feb 2011 GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
23 Feb 2011 Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
22 Feb 2011 Dynavax Reports New Phase 1a and Phase 1b Data for Universal Flu Vaccine Candidate
22 Feb 2011 Dynavax Reports Additional Positive Phase 1B Immunogenicity Data for Hepatitis B Therapy Candidate
22 Feb 2011 Transgene Announces the Termination by Roche of the License Agreement on TG4001/RG3484 for the Treatment of Diseases Caused by the Human Papilloma Virus (''HPV'')
21 Feb 2011 Intercell announces start of pivotal Phase II/III study in India for vaccine to protect children from Japanese Encephalitis
18 Feb 2011 Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine
18 Feb 2011 NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
18 Feb 2011 Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
16 Feb 2011 New Pneumococcal Vaccine Approach Successful in Early Tests
14 Feb 2011 Diamyd Medical: Last Patient Completes the EU Phase III Study of Diamyd® Antigen Based Therapy for Type 1 Diabetes

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top